Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France

Nine drugs have been marketed for 10 years for the treatment of advanced melanoma (AM). With half of patients reaching a second line, the optimal sequence of treatments remains unclear. To inform policy-makers about their efficiency, we performed a cost-effectiveness analysis of sequential strategie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandel, Marguerite, Bardet, Aurélie, Dalle, Stéphane, Allayous, Clara, Mortier, Laurent, Guillot, Bernard, Dutriaux, Caroline, Leccia, Marie-Thérèse, Dalac, Sophie, Montaudie, Henri, Saiag, Philippe, Legoupil, Delphine, Brunet-Possenti, Florence, Arnault, Jean-Philippe, Quatrebarbes, Julie De, Beylot-Barry, Marie, Maubec, Eve, Lesimple, Thierry, Aubin, François, Grob, Jean-Jacques, Granel-Brocard, Florence, Stoebner, Pierre-Emmanuel, Dupuy, Alain, Dreno, Brigitte, Michiels, Stefan, Lebbe, Céleste, Borget, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777106/
https://www.ncbi.nlm.nih.gov/pubmed/36547139
http://dx.doi.org/10.3390/curroncol29120725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777106/
https://www.ncbi.nlm.nih.gov/pubmed/36547139
http://dx.doi.org/10.3390/curroncol29120725

Ejemplares similares